Currently, there are 253.14M common shares owned by the public and among those 244.79M shares have been available to trade.
The company’s stock has a 5-day price change of -4.16% and -48.00% over the past three months. CLSK shares are trading -18.50% year to date (YTD), with the 12-month market performance up to 113.54% higher. It has a 12-month low price of $3.38 and touched a high of $24.72 over the same period. CLSK has an average intraday trading volume of 25.72 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -8.66%, -29.04%, and -37.00% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Cleanspark Inc (NASDAQ: CLSK) shares accounts for 41.06% of the company’s 253.14M shares outstanding.
It has a market capitalization of $2.28B and a beta (3y monthly) value of 4.19. The earnings-per-share (ttm) stands at -$0.78. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.08% over the week and 6.97% over the month.
Earnings per share for the fiscal year are expected to decrease by -463.33%, and 88.91% over the next financial year.
Looking at the support for the CLSK, a number of firms have released research notes about the stock. JP Morgan stated their Neutral rating for the stock in a research note on December 08, 2023, with the firm’s price target at $9-$8. Bernstein coverage for the Cleanspark Inc (CLSK) stock in a research note released on October 31, 2023 offered a Outperform rating with a price target of $5.30. JP Morgan was of a view on October 11, 2023 that the stock is Overweight, while Cantor Fitzgerald gave the stock Overweight rating on December 09, 2022, issuing a price target of $5. H.C. Wainwright on their part issued Buy rating on July 26, 2022.
